| Mechela Lanece Barnes, | |
|
1959 Ne Pacific St, Seattle, WA 98195-0001 | |
| (206) 598-3300 | |
| Not Available |
| Full Name | Mechela Lanece Barnes |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 1959 Ne Pacific St, Seattle, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265048987 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | AP61450741 (Washington) | Primary |
| 163WM0102X | Registered Nurse - Maternal Newborn | RN60857520 (Washington) | Secondary |
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Medical & Biological Laboratories Co., Ltd. (MBL), with the collaboration of Osaka University, has successfully generated several fully human monoclonal antibodies against pandemic A (H1N1 and H3N2) type influenza virus by utilizing blood samples from volunteers who were inoculated with influenza vaccine.
An efficient, high-volume technique for testing potential drug treatments for Alzheimer's disease uncovered an organic compound that restored motor function and longevity to fruit flies with the disease, according to new research that could help put the search for an effective Alzheimer's drug on a faster track.
Exsulin Corporation today announced the start of a phase II human clinical trial of Exsulin, a peptide drug product aimed at restoring insulin production in people with diabetes mellitus. The randomized, controlled 12-week trial in patients with established Type 1 diabetes (T1DM) will be co-led by Mayo Clinic in Rochester, Minn., and McGill University Health Centre in Montreal, Canada.
According to scientific estimations, humans are exposed to at least 10,000 to 100,000 environmental and exogenous compounds in an individual lifetime, which are mainly absorbed through our dietary.
"Aid agencies say water and food provision has improved in four camps housing more than 105,000 refugees from Sudan's Blue Nile State, but flooding, disease and an influx of additional refugees pose new threats," IRIN reports, noting, "Sudan's government forces and rebels have been fighting in Blue Nile State since September 2011, sending refugees south."
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mechela Lanece Barnes, Po Box 50095, Seattle, WA 98145-5095 Ph: () - | Mechela Lanece Barnes, 1959 Ne Pacific St, Seattle, WA 98195-0001 Ph: (206) 598-3300 |
News Archive
Medical & Biological Laboratories Co., Ltd. (MBL), with the collaboration of Osaka University, has successfully generated several fully human monoclonal antibodies against pandemic A (H1N1 and H3N2) type influenza virus by utilizing blood samples from volunteers who were inoculated with influenza vaccine.
An efficient, high-volume technique for testing potential drug treatments for Alzheimer's disease uncovered an organic compound that restored motor function and longevity to fruit flies with the disease, according to new research that could help put the search for an effective Alzheimer's drug on a faster track.
Exsulin Corporation today announced the start of a phase II human clinical trial of Exsulin, a peptide drug product aimed at restoring insulin production in people with diabetes mellitus. The randomized, controlled 12-week trial in patients with established Type 1 diabetes (T1DM) will be co-led by Mayo Clinic in Rochester, Minn., and McGill University Health Centre in Montreal, Canada.
According to scientific estimations, humans are exposed to at least 10,000 to 100,000 environmental and exogenous compounds in an individual lifetime, which are mainly absorbed through our dietary.
"Aid agencies say water and food provision has improved in four camps housing more than 105,000 refugees from Sudan's Blue Nile State, but flooding, disease and an influx of additional refugees pose new threats," IRIN reports, noting, "Sudan's government forces and rebels have been fighting in Blue Nile State since September 2011, sending refugees south."
› Verified 6 days ago
Noelle D Brodeur, CNM, ARNP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1101 Madison St Ste 700, Seattle, WA 98104 Phone: 206-215-6300 Fax: 206-215-6301 | |
Victoria G Speck, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 5350 Tallman Ave Nw Ste 420, Seattle, WA 98107 Phone: 206-781-6161 Fax: 206-781-6285 | |
Aliscia Rose Lindeke, CNM, RN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 401 Broadway, Suite 2075, Seattle, WA 98104 Phone: 206-744-1600 | |
Deborah Blue, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 10330 Meridian Ave N, Suite 190, Seattle, WA 98133 Phone: 206-368-6670 | |
Megan Kathleen Dunn, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-520-5000 | |
Kimberly A Kight Johansen, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St., Seattle, WA 98195 Phone: 206-520-5000 | |
Mia Elizabeth Pelt, RN, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 5350 Tallman Ave Nw, Suite 420, Seattle, WA 98107 Phone: 206-781-6080 |